Bristol-Myers Squibb Co (BMY)
44.54
-0.16
(-0.37%)
USD |
NYSE |
May 15, 16:00
44.54
0.00 (0.00%)
After-Hours: 16:25
Bristol-Myers Squibb Market Cap: 90.30B for May 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 14, 2024 | 90.63B |
| May 13, 2024 | 91.34B |
| May 10, 2024 | 91.10B |
| May 09, 2024 | 90.69B |
| May 08, 2024 | 88.52B |
| May 07, 2024 | 89.27B |
| May 06, 2024 | 88.99B |
| May 03, 2024 | 89.17B |
| May 02, 2024 | 88.58B |
| May 01, 2024 | 89.62B |
| April 30, 2024 | 89.07B |
| April 29, 2024 | 90.49B |
| April 26, 2024 | 90.92B |
| April 25, 2024 | 90.61B |
| April 24, 2024 | 99.04B |
| April 23, 2024 | 99.31B |
| April 22, 2024 | 99.61B |
| April 19, 2024 | 99.19B |
| April 18, 2024 | 97.91B |
| April 17, 2024 | 96.97B |
| April 16, 2024 | 97.82B |
| April 15, 2024 | 98.33B |
| April 12, 2024 | 97.86B |
| April 11, 2024 | 99.57B |
| April 10, 2024 | 101.94B |
| Date | Value |
|---|---|
| April 09, 2024 | 104.59B |
| April 08, 2024 | 103.58B |
| April 05, 2024 | 104.03B |
| April 04, 2024 | 104.19B |
| April 03, 2024 | 105.77B |
| April 02, 2024 | 106.90B |
| April 01, 2024 | 107.41B |
| March 28, 2024 | 109.91B |
| March 27, 2024 | 107.92B |
| March 26, 2024 | 106.51B |
| March 25, 2024 | 105.90B |
| March 22, 2024 | 105.25B |
| March 21, 2024 | 104.56B |
| March 20, 2024 | 105.15B |
| March 19, 2024 | 104.99B |
| March 18, 2024 | 104.56B |
| March 15, 2024 | 106.08B |
| March 14, 2024 | 106.38B |
| March 13, 2024 | 106.47B |
| March 12, 2024 | 110.01B |
| March 11, 2024 | 109.93B |
| March 08, 2024 | 108.77B |
| March 07, 2024 | 107.74B |
| March 06, 2024 | 107.94B |
| March 05, 2024 | 104.79B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
69.96B
Minimum
Jul 22 2019
172.50B
Maximum
Dec 02 2022
131.50B
Average
137.93B
Median
Market Cap Benchmarks
| Amgen Inc | 171.17B |
| Gilead Sciences Inc | 83.48B |
| Johnson & Johnson | 367.48B |
| Eli Lilly and Co | 748.54B |
| 2seventy bio Inc | 250.34M |
Market Cap Related Metrics
| PS Ratio | 2.011 |
| Price to Book Value | 5.476 |
| Price to Free Cash Flow | 7.320 |
| Price | 44.54 |
| Earnings Yield | -6.96% |
| Operating PE Ratio | 12.58 |
| Normalized PE Ratio | 57.68 |